Werkgroep Cardiologische centra Nederland

MK021 (Completed)

A 24-Week, Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Assess Anacetrapib When Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low HDL-C
Medicine
Anacetrapib
Population
Diabetes mellitus
Phase
III
Starting year
2012

Contact

dr. J. Schaap (Cardioloog)
Breda, Amphia Ziekenhuis